THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent
agonist of the CB1 receptor and has been sold online as a designer drug.
It is a structural analog of AM-2201 in which the central indole ring has been replaced by
indazole.
Cannabinoids are commonly smoked or vaporized to achieve a quick onset of effects and
rapid offset. THJ-2201 is orally active when dissolved in a lipid, which can increase the
duration significantly. Like other cannabinoids, it is insoluble in water but dissolves in
ethanol and lipids.
TECHNICAL INFORMATION
| Formal Name | [1-(5-fluoropentyl)-1H-indazol-3-yl]-1-naphthalenyl-methanone |
| CAS Number | 1801552-01-1 |
| Synonyms |
|
| Molecular Formula | C23H21FN2O |
| Formula Weight | 360.4 |
| Purity | ≥98% |
| Formulation | A crystalline solid |
| λmax | 219, 320 nm |
| SMILES | O=C(C1=CC=CC2=C1C=CC=C2)C3=NN(CCCCCF)C4=C3C=CC=C4 |
| InChI Code | 1S/C23H21FN2O/c24-15-6-1-7-16-26-21-14-5-4-12-20(21)22(25-26)23(27)19-13-8-10-17-9-2-3-11-18(17)19/h2-5,8-14H,1,6-7,15-16H2 |
| InChI Key | DULWRYKFTVFPTL-UHFFFAOYSA-N |
WARNING - This product is not for human or veterinary use.
SHIPPING & STORAGE
| Storage | -20°C |
| Shipping | Room temperature in continental US; may vary elsewhere |
| Stability | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
没有评论:
发表评论